Update in the epidemiology, risk factors, screening, and treatment of diabetic retinopathy

Despite progress in the treatment of diabetic macular edema and diabetic retinopathy, the rate of lower fundus examination due to limitations of medical resources delays the diagnosis and treatment of diabetic retinopathy. Therefore, implementation of automated diabetic retinopathy screening program and the identification of more specific and sensitive biomarkers are important for facilitating the earlier detection of diabetic macular edema and diabetic retinopathy to decrease the prevalence of poor vision and blindness.

Automated summary

Despite advancements in treating diabetic macular edema and retinopathy, limited medical resources contribute to lower fundus examination rates, delaying diagnosis and treatment. Implementation of automated screening programs and identification of specific biomarkers are crucial for early detection, reducing the prevalence of poor vision and blindness.